Allogene Therapeutics, Inc. (ALLO)
1.70
+0.01
(+0.59%)
USD |
NASDAQ |
Feb 10, 16:00
1.70
0.00 (0.00%)
After-Hours: 18:18
Allogene Therapeutics EPS Diluted (Quarterly) : -0.1864 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.40M |
| Total Expenses (Quarterly) | 41.40M |
| Enterprise Value | 212.74M |
| Earnings Yield | -57.71% |
| Normalized Earnings Yield | -57.27 |